CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Intercell

For profitContributed to NME
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

May 1, 2006

First marketed drug

Mar 30, 2009

First NDA

Mar 30, 2009

Last known activity

May 1, 2011

Acquired by Valneva on Jan 1, 2013

Timeline

1990s

  1. Jan 1, 1998

    Intercell— Founded

2000s

  1. Mar 30, 2009

    inactivated japanese encephalitis vaccine— NDA Organization

2010s

  1. Jan 1, 2013

    Valneva— Acquired By

Drugs by trial phase (3 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (10)

Details

Founded
Vienna, AT Jan 1, 1998
First NDA
Mar 30, 2009
Last known activity
May 1, 2011

Notes

Acquired by Vivalis 12 Dec 2012